Glenna Mileson - 18 Jan 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Financial Officer
Signature
/s/ Glenna Mileson
Issuer symbol
ATHA
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 16:28:37 UTC
Previous filing
06 Jan 2022
Next filing
12 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +170,000 $0.000000 170,000 18 Jan 2022 Common Stock 170,000 $10.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.